Certificates Of Analysis Suggested As Alternative To Site-Specific Stability
Executive Summary
Certificates of analysis from three commercial-scale validation batches could provide assurance that technology transfer has been successfully completed from a pilot manufacturing site to a commercial site, the Pharmaceutical Science Advisory Committee Site Specific Subcommittee determined Sept. 22.